Amyotrophic lateral sclerosis: The search for a spectroscopic marker of upper motoneuron involvement

Archives of Neurology

Volumn 58, Issue 5, 2001, Pages 714-716

  Bowen, B C ^a   Bradley, W G ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID DERIVATIVE; N ACETYLASPARTIC ACID; N ASPARTYLGLUTAMATE; UNCLASSIFIED DRUG;

AMYOTROPHIC LATERAL SCLEROSIS; BRAIN METABOLISM; CLINICAL EXAMINATION; CLINICAL FEATURE; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; EDITORIAL; ELECTROPHYSIOLOGY; HUMAN; MOTOR CORTEX; MUSCLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

EID: 0035003304     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.58.5.714     Document Type: Editorial

References (17)

1. MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis
2. Preliminary results of proton magnetic resonance spectroscopy in motor neurone disease (amytrophic lateral sclerosis)
3. Quantification of brain metabolites in amyotrophic lateral sclerosis by localized proton magnetic resonance spectroscopy
4. Proton magnetic resonance spectroscopy of the primary motor cortex in patients with motor neuron disease: Subgroup analysis and follow-up measurements
5. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy
6. A proton magnetic resonance spectroscopic study in ALS: Correlation with clinical findings
7. Motor neuron diseases: Comparison of single-voxel proton MR spectroscopy of the motor cortex with MR imaging of the brain
8. 1H-magnetic resonance spectroscopy in amyotrophic lateral sclerosis
9. Proton magnetic resonance spectroscopy of the motor cortex in 70 patients with amyotrophic lateral sclerosis
10. Detection of cortical neuron loss in motor neuron disease by proton magnetic resonance spectroscopic imaging in vivo
11. Decreased N-acetylaspartate in motor cortex and corticospinal tract in ALS
12. 1H-MRS evidence of neurodegeneration and excess glutamate+glutamine in ALS medulla
13. In vivo quantitation of metabolite concentrations in the brain by means of proton MRS
14. Recovery of N-acetylaspartate in corticomotor neurons of patients with ALS after riluzole therapy
15. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis
16. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: A hypothesis
17. Estimation of metabolite concentrations from localized in vivo proton NMR spectra